Effect of ursodeoxycholic acid on HCV replication in subtyped chronic hepatitis C.

scientific article published on June 1996

Effect of ursodeoxycholic acid on HCV replication in subtyped chronic hepatitis C. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/BF02088249
P698PubMed publication ID8654164

P50authorWolfgang StremmelQ50772068
P2093author name stringT Goeser
L Theilmann
M Mohler
S Seipp
U Tox
P2860cites workA multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study GroupQ28243457
Transient immunoglobulin M antibody response to hepatitis C virus capsid antigen in posttransfusion hepatitis C: putative serological marker for acute viral infectionQ33612002
Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosisQ39514969
Significance of IgM antibody to hepatitis C virus in patients with chronic hepatitis CQ41836952
Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes.Q50878460
Immunomodulatory effects of ursodeoxycholic acid on immune responsesQ68225187
Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acidQ68925952
Ursodiol in the long-term treatment of chronic hepatitis: a double-blind multicenter clinical trialQ72347760
The effect of ursodeoxycholic acid on serum enzymes and liver histology in patients with chronic active hepatitis. A 12-month double-blind, placebo-controlled trialQ72682269
P433issue6
P304page(s)1276-1277
P577publication date1996-06-01
P1433published inDigestive Diseases and SciencesQ15716711
P1476titleEffect of ursodeoxycholic acid on HCV replication in subtyped chronic hepatitis C
P478volume41

Reverse relations

Q73562590Long-term efficacy of interferon-alpha and ursodeoxycholic acid in treatment of chronic type C hepatitiscites workP2860

Search more.